J. Goldman & Co’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$958K Buy
+27,100
New +$841K 0.03% 425
2025
Q2
Sell
-42,700
Closed -$1.41M 450
2025
Q1
$1.41M Buy
+42,700
New +$1.39M 0.03% 333
2024
Q2
Sell
-13,500
Closed -$365K 433
2024
Q1
$365K Buy
+13,500
New +$383K 0.01% 342
2023
Q4
Sell
-45,000
Closed -$1.26M 336
2023
Q3
$1.26M Buy
+45,000
New +$1.32M 0.04% 229
2015
Q4
Sell
-9,000
Closed -$528K 228
2015
Q3
$528K Buy
+9,000
New +$594K 0.05% 184

Other funds holding ALKS

J. Goldman & Co's ALKS Position: Q3 2025 in Review

J. Goldman & Co sold out of Alkermes (ALKS) in Q3 2025, closing a stake of 21,425 shares — an estimated $613K sold.

J. Goldman & Co first reported a position in ALKS in Q1 2021 and held it in 5 quarters. The position peaked at $5.16M in Q2 2022. 358 funds tracked by Wall St. Rank hold ALKS as of Q3 2025.

  • J. Goldman & Co reported no remaining Alkermes position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 21,425 Alkermes shares in Q3 2025, an estimated $613K.
  • J. Goldman & Co first reported a position in Alkermes in Q1 2021 and held it in 5 quarters.
  • J. Goldman & Co's Alkermes position peaked at $5.16M in Q2 2022.
  • 358 funds tracked by Wall St. Rank held Alkermes as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.